Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Incyte Corporation
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Janssen Research & Development, LLC
Baylor Breast Care Center
Mayo Clinic
Janssen Research & Development, LLC
University of Michigan Rogel Cancer Center
Karyopharm Therapeutics Inc
Memorial Sloan Kettering Cancer Center
Stanford University
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Incyte Corporation
M.D. Anderson Cancer Center
iOnctura
Massachusetts General Hospital
OHSU Knight Cancer Institute
Incyte Corporation
AbbVie
National Institutes of Health Clinical Center (CC)
Novartis
University of Washington
Incyte Corporation
Children's Hospital of Philadelphia
Big Ten Cancer Research Consortium
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
Ohio State University Comprehensive Cancer Center
Dana-Farber Cancer Institute
Mayo Clinic
University Health Network, Toronto
Federal Research Institute of Pediatric Hematology, Oncology and Immunology